Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Operations (2016 - 2025)

Anaptysbio (ANAB) has disclosed Cash from Operations for 10 consecutive years, with 97997000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 246.98% year-over-year to 97997000.0, compared with a TTM value of 19697000.0 through Dec 2025, up 114.55%, and an annual FY2025 reading of 19697000.0, up 114.55% over the prior year.
  • Cash from Operations was 97997000.0 for Q4 2025 at Anaptysbio, up from 27356000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 97997000.0 in Q4 2025 and bottomed at 66672000.0 in Q4 2024.
  • Average Cash from Operations over 5 years is 17797650.0, with a median of 23675500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations plummeted 351.77% in 2022, then surged 246.98% in 2025.
  • Year by year, Cash from Operations stood at 25301000.0 in 2021, then surged by 57.77% to 10685000.0 in 2022, then tumbled by 221.47% to 34349000.0 in 2023, then tumbled by 94.1% to 66672000.0 in 2024, then soared by 246.98% to 97997000.0 in 2025.
  • Business Quant data shows Cash from Operations for ANAB at 97997000.0 in Q4 2025, 27356000.0 in Q3 2025, and 40244000.0 in Q2 2025.